Novel heparan sulfate structures revealed by monoclonal antibodies. - Wikidata - thesis-toulmin - TriplyDB

Novel heparan sulfate structures revealed by monoclonal antibodies.

Novel heparan sulfate structures revealed by monoclonal antibodies.

http://www.wikidata.org/entity/Q46391304

about

Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88 Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma Iduronic acid in chondroitin/dermatan sulfate affects directional migration of aortic smooth muscle cells 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.rd1 mouse retina shows imbalance in cellular distribution and levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and sulfated glycosaminoglycans.Molecular changes in the vasculature of injured tissues Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.High sodium diet converts renal proteoglycans into pro-inflammatory mediators in rats Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder.Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis.The detection of glycosaminoglycans in pancreatic islets and lymphoid tissues.Heparan sulfate expression in the neural crest is essential for mouse cardiogenesis.Acute UV irradiation increases heparan sulfate proteoglycan levels in human skin.Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development.Heparanase: a target for drug discovery in cancer and inflammation.Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions.Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.Proteoglycomics: recent progress and future challenges.Functions of chondroitin sulfate and heparan sulfate in the developing brain.RB4CD12 epitope expression and heparan sulfate disaccharide composition in brain vasculature.Involvement of Ext1 and heparanase in migration of mouse FBJ osteosarcoma cells.Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell line.HSulf-1 inhibits cell proliferation and invasion in human gastric cancer.Chondroitin sulphate and heparan sulphate sulphation motifs and their proteoglycans are involved in articular cartilage formation during human foetal knee joint development.Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue.Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan.Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix.Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.Roles of heparan sulfate sulfation in dentinogenesis Hepatic syndecan-1 changes associate with dyslipidemia after renal transplantation.Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis.Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells.

P2860

Q24328759-FAB83BA7-305D-48D8-86F2-FA754A9A84E7 Q27001749-A3BA4AF3-6735-434B-8176-B504222AB98C Q27313839-6BF7C46F-D71E-41CF-9547-56A99A15F2CB Q33230192-696C64B4-42D2-4AA6-BE7E-772A838BF20A Q33230201-F05EDDDD-86B9-40F0-8F80-4AB1664F9742 Q33289271-F6F9A46B-AC19-490A-B6FD-C20790CE4522 Q33637014-6D31FDA2-01C8-4421-8E6C-DC4A49528346 Q33778582-6E4BD02D-4F77-4192-9F7D-2DE04E18225A Q33850265-5EB4C18A-7AF5-4813-B7E8-6F719C904D75 Q33943403-9E323A7B-A555-43A0-AF19-B06F74E841A9 Q34036662-72E8BE6D-FE99-44DC-B733-C45E1F101ADE Q34075861-D2A23E09-1588-4863-84ED-FD35B2294333 Q34344501-C13B51EB-BDC7-43A6-A993-6E95222BB1B5 Q34411156-FE907417-6A09-4C05-A12D-5B55F598C59C Q34522475-2ABA7B09-AE07-40B8-AA88-1DAF72AF6E99 Q35072854-0FF648A6-4A76-413B-8F19-B06A01C739CF Q35778445-704D41E4-2225-4E0E-ABAE-282C9621613C Q35826330-AF50979C-6A96-4228-A548-0E933A02F5D3 Q36084654-3754098E-75B1-4533-9A2B-F03C5338F0A1 Q36752653-7A9F2234-EF31-453C-9A48-AFF8B95C934B Q36980992-F769A85D-EB8E-4A8B-A1BD-EF6358256BC7 Q37211809-B27E47E6-E5AF-4E6A-B4E9-440980C697AA Q37352004-9EA684D3-15B2-48F0-9E20-26712C5FB688 Q37745062-855921D7-0988-4B6F-A1F4-910F34A3210F Q37812566-F786F18E-922C-4715-BE81-361F594EB13F Q38332967-47E3FFFF-15BA-413D-813C-E3578CBDAAAE Q39262117-048D3BCF-876A-4EBD-8EF7-1E182645C09D Q39300907-A63ACFA8-3BCF-4F39-B0EF-7114DBBD3353 Q39514539-8A5079E9-610D-4243-9DB2-56D0CE93CA75 Q39614512-82FECB19-1C64-4578-9C28-4D86DB45917E Q40046334-C00056D2-6CEA-4F51-B73A-36D94870D7EE Q40115880-2C36F1D8-7A84-4B18-BEA3-20E2748D284B Q40380295-72A00FC7-5371-486B-A646-B0973C26FCFF Q41261844-849EEEA0-B904-486E-9441-84A57C2BC1C1 Q41808585-BCFB355A-406F-4F3E-823B-8731A8490CB3 Q42276166-0DFBEDD5-D118-44DB-94E4-362760EF3E18 Q42554864-39127B0E-F62A-4F30-9415-4312283B62AF Q42678793-2DAD4C30-6235-4B19-B885-CB0629DA8A8E Q42742727-D7EDE826-7484-429D-9329-C6B2A4B0C57B Q43010856-F1F0F427-6B35-481A-AE88-8096955D79FB

P2860

Novel heparan sulfate structures revealed by monoclonal antibodies.

http://www.wikidata.org/entity/Q46391304

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Novel heparan sulfate structures revealed by monoclonal antibodies.

@en

Novel heparan sulfate structures revealed by monoclonal antibodies.

@nl

type

label

Novel heparan sulfate structures revealed by monoclonal antibodies.

@en

Novel heparan sulfate structures revealed by monoclonal antibodies.

@nl

prefLabel

Novel heparan sulfate structures revealed by monoclonal antibodies.

@en

Novel heparan sulfate structures revealed by monoclonal antibodies.

@nl

P1433

Q46391304-AA1128E8-DADC-4225-8A7C-86949BBADC7B

P1476

Q46391304-6D93C8A7-CB3B-4362-8240-C637FC5AB121

P2093

Q46391304-09B8BE46-897E-40F0-AB7E-BC96B66AEFC6

Q46391304-0FD49BAD-1206-4B6F-943A-8E561CDCBFE3

Q46391304-2C6C88B4-A0F7-44E0-B19D-2141AABE816C

Q46391304-4E1DF22B-217E-45BD-BFF0-2920EA385716

Q46391304-64A53B08-7E31-464A-98A0-16505A86CD64

Q46391304-A36808AC-175F-4E4E-8B2F-D858CFD8DD3C

Q46391304-BBD0E5C3-2E04-4BDE-9C27-5ED248925C15

Q46391304-DE218D68-3BA7-477E-8638-9B79346CDF23

P2860

Q46391304-029F5BB7-68FD-42B0-9681-7D63F2E31973

Q46391304-05DE89F1-ACA2-441B-92AE-37414C5A2D73

Q46391304-0B5D04F2-6610-4224-B341-DD127AC41F40

Q46391304-10C76234-D65D-40D1-B4C6-BA6C28DFEA1C

Q46391304-13D57A2B-F482-42AD-B8A3-619B21E8A4DC

Q46391304-160CFDC8-C983-4A39-8EBB-79754AE374B1

Q46391304-35EC61CB-CB21-4B9B-A7B6-AF2A7153D440

Q46391304-3838866C-9FD3-4DAE-9870-1B9C4CB3F451

Q46391304-3E51B7D7-5520-40F6-A78C-9E09645B6395

Q46391304-455505BB-9056-43CB-B597-7D75D7B2F615

P304

Q46391304-FE38C8BA-3B66-4BAE-8156-0786C6F3B5D6

P31

Q46391304-D8B011BB-199E-4412-B564-7B2AFCBCAE9A

P356

Q46391304-AB5F23D4-AE5F-4B16-8C48-F54D022582DE

P407

Q46391304-CBC2BA88-4BFD-48E1-B84E-573C9AAE50DA

P433

Q46391304-3229809D-B233-467E-9C67-95571C4F1B6F

P478

Q46391304-E47B292C-3F9B-4756-98DC-C8FDC3A939E8

P577

Q46391304-D5B46C3A-79B3-48BC-8A11-731B61305B7D

P698

Q46391304-5A7E0F02-F0E5-46A3-AC7E-B9737816ABAD

P921

Q46391304-5D592FB2-EFF2-4932-9A95-D27AF5C84DA6

P356

P1433

Journal of Biological Chemistry

P1476

Novel heparan sulfate structures revealed by monoclonal antibodies.

@en

P2093

Jacob van den Born

http://www.w3.org/2001/XMLSchema#string

Katriina Salmivirta

http://www.w3.org/2001/XMLSchema#string

Keiichi Yoshida

http://www.w3.org/2001/XMLSchema#string

Markku Salmivirta

http://www.w3.org/2001/XMLSchema#string

Nina Ostman

http://www.w3.org/2001/XMLSchema#string

Shuichi Miyaura

http://www.w3.org/2001/XMLSchema#string

Takeshi Ishimaru

http://www.w3.org/2001/XMLSchema#string

Tiina Henttinen

http://www.w3.org/2001/XMLSchema#string

P2860

Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species

Expression of heparan sulphate L-iduronyl 2-O-sulphotransferase in human kidney 293 cells results in increased D-glucuronyl 2-O-sulphation

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling

Regulated diversity of heparan sulfate

Functions of cell surface heparan sulfate proteoglycans

Nitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes.

Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns.

Enamel knots as signaling centers linking tooth morphogenesis and odontoblast differentiation.

Epithelial-mesenchymal signalling regulating tooth morphogenesis.

P304

20516-20523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M502065200

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15778504

http://www.w3.org/2001/XMLSchema#string

P921